Corvus Pharmaceuticals
CRVS
10.41
-0.15
-1.42%
Corvus Pharmaceuticals
US · CRVS
#3339 by market cap
Listed 2016
10.41
-0.15
-1.42%
Live - 5344 symbols - heartbeat 441s ago
· 2026-10-08 08:12
Pre-market
10.13
-2.69%
After-hours
10.52
+1.06%
- Market cap
- 875.70M
- P/E (TTM)i
- -16.27
- P/Bi
- 3.89
- EPSi
- -0.53
- Div yieldi
- 0.00%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on CRVS?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 4 analysts
Buy
Avg price target
29.50 +183.4%
Price target rangecurrent 10.41
Low27.00
Avg29.50
High33.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-08-11 | Mizuho Securities | -- | BUY | 30.00 |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 27.00 |
| 2026-08-07 | Barclays | -- | BUY | 28.00 |
| 2026-08-07 | Oppenheimer | -- | BUY | 33.00 |
| 2026-07-01 | H.C. Wainwright | -- | BUY | 27.00 |
| 2026-06-12 | Mizuho Securities | -- | BUY | 30.00 |
| 2026-05-18 | Mizuho Securities | -- | BUY | 30.00 |
| 2026-05-15 | H.C. Wainwright | -- | BUY | 27.00 |
| 2026-05-15 | Barclays | -- | BUY | 28.00 |
| 2026-05-14 | Goldman Sachs | -- | BUY | 40.00 |
| 2026-05-11 | Mizuho Securities | -- | BUY | 30.00 |
| 2026-05-11 | Goldman Sachs | -- | BUY | 40.00 |
| 2026-05-08 | Barclays | -- | BUY | 28.00 |
| 2026-04-17 | Goldman Sachs | -- | BUY | 40.00 |
| 2026-03-16 | Mizuho Securities | -- | BUY | 30.00 |
| 2026-03-16 | Barclays | -- | BUY | 28.00 |
| 2026-03-13 | H.C. Wainwright | -- | BUY | 27.00 |
| 2026-03-13 | Oppenheimer | -- | BUY | 33.00 |
| 2026-02-19 | Mizuho Securities | -- | BUY | 30.00 |
| 2026-01-29 | Mizuho Securities | -- | BUY | 30.00 |
| 2026-01-22 | Jefferies | -- | BUY | 42.00 |
| 2026-01-21 | Oppenheimer | -- | BUY | 32.00 |
| 2026-01-20 | Mizuho Securities | -- | BUY | 20.00 |
| 2026-01-20 | H.C. Wainwright | -- | BUY | 27.00 |
| 2026-01-20 | Barclays | -- | BUY | 28.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±12.80% | +0.43% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±11.89% | +6.58% (in line) |
| 2025/Q4 | 2026-03-12 | After close | ±12.26% | -4.31% (in line) |
| 2025/Q3 | 2025-11-04 | After close | ±18.39% | -1.44% (in line) |
| 2025/Q2 | 2025-08-07 | After close | ±19.90% | +4.36% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±43.46% | +32.24% (in line) |
| 2024/Q4 | 2025-03-25 | After close | ±37.68% | -14.76% (in line) |
| 2024/Q3 | 2024-11-12 | After close | ±24.87% | +2.07% (in line) |
| 2024/Q2 | 2024-08-06 | After close | ±20.33% | +9.67% (in line) |
| 2024/Q1 | 2024-05-06 | After close | ±28.80% | -12.04% (in line) |
| 2023/Q4 | 2024-03-19 | After close | ±44.13% | -5.61% (in line) |
| 2023/Q3 | 2023-11-07 | -- | ±28.48% | +1.27% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:12:11 · For reference only, not investment advice and not tailored to your situation.